Publication | Closed Access

Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT

Positron Emission TomographyUrologyMedical ImagingGastrin-releasing Peptide ReceptorMedicinePreliminary ResultsProstatic DiseaseOncologyMolecular ImagingRecurrent Prostate CancerNuclear MedicineRadiologyHealth Sciences